Skip to main content

CM Ballantyne

First name:
CM
Last name:
Ballantyne
Vazir, A. ., Claggett, B. ., Cheng, S. ., Skali, H. ., Shah, A. ., Agulair, D. ., … Solomon, S. . (2018). Association of Resting Heart Rate and Temporal Changes in Heart Rate With Outcomes in Participants of the Atherosclerosis Risk in Communities Study. JAMA Cardiology. https://doi.org/10.1001/jamacardio.2017.4974 (Original work published 2018)
Bhatt, D. ., Steg, P. ., Miller, M. ., Brinton, E. ., Jacobson, T. ., Ketchum, S. ., … REDUCE-IT, I. . (2019). Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. The New England Journal of Medicine, 380(1), 11-22. https://doi.org/10.1056/NEJMoa1812792 (Original work published 2019)
Verma, S. ., Bhatt, D. ., Steg, P. ., Miller, M. ., Brinton, E. ., Jacobson, T. ., … REDUCE-IT, I. . (2021). Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG. Circulation, 144(23), 1845-1855. https://doi.org/10.1161/CIRCULATIONAHA.121.056290 (Original work published 2021)